AAV Production in HEK293 Cells: A Lab Protocol | NIIMBL

Added:

AV2 Production
Safety Setup
Cell Thawing
Cell Expansion
Cell Counting
Transfection Prep
Triple Transfection
Harvesting
Purification
Analysis

AV2 Production

0:07
Playing Section
  • 1

    Introduces AAV2 biomanufacturing project and training protocol needs.

  • 2

    Choice of AAV2 due to well-known nature and easy material access.

  • 3

    Safety level is low when following standard regulations.

Basic biology of Adeno-Associated Virus (AAV) and its structure, genome, and role as a gene delivery vector.
Fundamental principles of mammalian cell culture, specifically the maintenance and scaling of suspension HEK293 cell lines.
The concept of transient transfection and the triple-plasmid transfection system commonly used for AAV production.
Basic laboratory techniques in biochemistry, such as cell lysis methods and fundamental chromatography principles.
Analytical characterization methods for AAV vectors, including qPCR/ddPCR for genome titer and ELISA for physical capsid titer.
Quality control standards and purity analysis of viral vectors using techniques like silver staining, SDS-PAGE, or transmission electron microscopy (TEM).
Process scale-up strategies to transition from shake flasks to controlled bioreactor systems for industrial viral vector manufacturing.
Regulatory pathways and Good Manufacturing Practices (GMP) required for producing clinical-grade gene therapy products.
2.2K views25likes25:13@innovatebioOriginal Release: 2021-12-04

This video demonstrates a complete protocol for producing Adeno-Associated Virus (AAV) type 2 particles in HEK293 suspension cells, covering cell culture expansion, triple transfection with three plasmids (vector, rep, and cap), cell lysis, centrifugation, and purification using chromatography with specific buffer systems (binding, wash, and elution buffers). The process requires BSL-2 containment, uses Thermo Fisher's HEK293 cells designed for suspension growth, and produces viral particles that must be separated from empty and partially filled capsids for therapeutic applications.